Type 2 Diabetes

The US Food and Drug Administration announced the approval of Jardiance (empagliflozin) to treat adults with type 2 diabetes.

New research shows that testosterone therapy does not significantly improve erectile function or lessen mild to moderate aging male symptoms in obese patients with type 2 diabetes mellitus.

Researchers at University of Texas Southwestern Medical Center may have discovered a protein that could help in the battle against excessive weight gain.

Clinicians must anticipate changes in kidney function during acute illness and surgical procedures, as well as frequently reassess metformin use in older patients, since kidney function declines predictably with age.

Premixed insulin--a basal and prandial product delivered in one injection--sounds like an ideal solution for patients who resist multidose insulin therapy. For some it is, but not for all. A case and the caveats, here.

Despite the debilitating symptoms associated with nonalcoholic fatty liver disease, an alarming proportion of primary care providers mistreat or overlook the disease in their patients

A wearable device for managing diabetic peripheral neuropathy has been cleared by the US Food and Drug Administration.

Treatment of patients with diabetes can be difficult, and specific concerns arise in the older population regarding the safety and efficacy of this high-alert medication.

There are 2 FDA-approved sodium-glucose contransporter-2 inhibitors available in the United States. Here, a concise review of advantages/disadvantages and considerations in patient selection.

Agent Orange exposure several decades earlier may increase morbidity from various diseases, some of which have rarely been explored in previous epidemiologic studies.

The debate continues around the effect of nonsurgical periodontal therapy on HbA1C levels in persons with type 2 diabetes and chronic periodontitis. Now, a critical review of the study that triggered the controversy.

Disproven medical theories and practices can be slow to change, and nowhere is this truer than in the field of clinical nutrition.

Since many patients have insulin resistance, prescribing insulin therapy for diabetes often requires trial and error.

Since many patients with night eating syndrome (NES) believe they will not fall back asleep until they ingest a full meal, it's no surprise that NES is associated with obesity and metabolic abnormalities.

Surgery may not be a permanent solution for type 2 diabetes control, but the procedure does offer immediate benefits.

Home glucose monitoring benefits patient and physician alike, but getting test strips is harder than ordering a PET scan. Why?

Patients with prediabetes gain better oral glucose tolerance with a novel GI microbiome modulator that also may improve diabetes treatment.

An endocrinologist from the University Hospital Basel in Switzerland discusses the role of inflammation in the pathogenesis of type 2 diabetes, outlining the reasons why clinicians should target inflammation when treating diabetics.

Physical fitness has a significant impact on renal function and chronic kidney disease in diabetes, according to a new study that provides hope for preventing or delaying the need for dialysis.

Researchers concluded daily low-dose aspirin regimens are associated with nearly a 50% decrease of pancreatic cancer risk.

When patients with diabetes or metabolic syndrome experience acute cardiac events, the subject of stents often arises.

You have reduced this patient's A1C to 6.9% by adding insulin. Suboptimal lipids and persistent hypertension now must be addressed. What change(s) would you make to her regimen?

Half of patients with pancreatic cancer have DM at diagnosis; long-standing type 1 or type 2 DM may increase the risk of pancreatic cancer by 40% to 100%. Which comes first? Consider the studies, here.

Researchers at Wake Forest Baptist Medical Center have released a study showing the potential of a dangerous interaction between a common supplement and prescription medication.

The Food and Drug Administration (FDA) has announced the approval of a new medication aimed at helping the nearly 26 million people in the country with diabetes.

Chronic kidney disease is common in patients with diabetes and can complicate treatment, but several agents may help. Here the focus is on incretin therapies.

A new pill could be the next tool in a patient's fight to lose weight, according to a recent study.

Obese and overweight patients who were treated with the drug liraglutide experienced significant weight loss and were less likely to develop type 2 diabetes than patients who received placebo.

A drug which has already been approved for patients with diabetes could have more benefits for people at risk of having heart disease, according a recent study.

An experimental, first-in-class drug that affects the gut microbiota has been shown to improve glucose tolerance and insulin sensitivity in adults with prediabetes.